Powered by Bioz** This cell line contains an expected karyotypic abnormality consistent with the phenotype indicated in the “”disease”” field below. Please see the karyotype report in the Product Information & Testing PDF(s) linked below for more information.
This induced pluripotent stem (iPS) cell line, which serves as a model for Down Syndrome (Trisomy 21), was created by reprogramming a trisomy of 21 (Ts21) human fibroblast line.
- Cell Line Alias 2DS3
- Unit of Measure (UOM) Vial
- Cell Type Human iPS
- Sex Male
- Age at Collection 1 Months
- Reprogramming Method Non-integrating (Sendai: Oct4, Klf4, Sox2, cMyc)
- Disease Down syndrome, Trisomy 21
- Genetic Alteration Mutation 47,XY,+21 (Trisomy 21)
- Pubmed Abstract Weick, JP et al. "Deficits in Human Trisomy 21 iPSCs and Neurons" PNAS 110.24 (2013): 9962-7
- hPSCReg ID WISCi006-A
- Provider University of Wisconsin - Dr. Anita Bhattacharyya
- Collections Down syndrome (Bhattacharyya) Collection
| Lot Number | Culture Platform | Lot Description | Banked By | Passage Number | Protocol | Product Information & Testing |
| WB20846 | mTeSR1/Matrigel | WiCell | 24 | WiCell Feeder Independent Pluripotent Stem Cell Protocol |